Drugs / IPV (Sinovac)®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT06690515 Comparator | Mar → Oct 2025 overdue | vaccinia | PT Bio Farma | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IPV (Sinovac) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06690515 ↗ |
| Modality | Vaccine | “IPV (Sinovac)® vaccine are injected intramuscularly into the right mid-lateral thigh region” NCT06690515 ↗ |
| Route | Intramuscular | “IPV (Sinovac)® vaccine are injected intramuscularly into the right mid-lateral thigh region” NCT06690515 ↗ |